Share
The newsletter Danish Pharmacovigilance Update
The newsletter Danish Pharmacovigilance Update puts focus on medicine and its side effects.
The purpose of Danish Pharmacovigilance Update is to give primarily doctors quick and easy access to the most important information about medicine and side effects.
The medicines in focus will be products that are subject to stricter reporting requirements, medicines used by particularly many people, or medicines which for any reason need special attention.
We hope that Danish Pharmacovigilance Update will make it clearer how Danish adverse reaction reports are used by the Danish Health and Medicines Authority and how they form part of joint efforts through our international cooperation.
Danish Pharmacovigilance Update is a monthly electronic newsletter issued in Danish every third Thursday.
-
05 March 2012 /News - miscellaneous
Danish Pharmacovigilance Update, 16 February 2012
Among the topics covered in this issue of Danish Pharmacovigilance Update are: Risk of overdose with methotrexate in the treatment of rheumatoid arthritis as well as intensified monitoring of heart rate and blood pressure in connection with treatment with Gilenya.
-
26 January 2012 /News - miscellaneous
Danish Pharmacovigilance Update, 19 January 2012
In this issue of Danish Pharmacovigilance Update read about the risk that patients treated with statins develop diabetes, and proton-pump inhibitors (PPI) and the risk of hypomagnesaemia with long-term use.
-
03 January 2012 /News - miscellaneous
-
01 December 2011 /News - miscellaneous
-
09 November 2011 /News - miscellaneous
-
26 September 2011 /News - miscellaneous
-
09 September 2011 /News - miscellaneous
-
27 June 2011 /News - miscellaneous
-
01 June 2011 /News - miscellaneous
-
13 May 2011 /News - miscellaneous
-
24 March 2011 /News - miscellaneous
-
03 March 2011
-
02 February 2011
-
10 January 2011
-
18 November 2010
-
10 November 2010
-
24 September 2010
-
02 September 2010
-
02 July 2010
-
28 May 2010
